Which groundbreaking FDA decision in the 1990s fundamentally transformed pharmaceutical advertising in the United States?

The pharmaceutical industry has a complex relationship with advertising and marketing, especially given the ethical considerations and regulatory frameworks that govern how medical products can be promoted. This trivia question explores a significant moment in pharmaceutical advertising history that changed how prescription medications are marketed to consumers in the United States.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

The 1997 relaxation of DTC (direct-to-consumer) broadcast advertising regulations, allowing TV ads to name both the drug and condition without full risk information
The 1992 mandate requiring all pharmaceutical advertisements to undergo pre-approval by an independent medical ethics board
The 1999 introduction of the 'Black Box Warning' system for high-risk medications in all advertisements
The 1995 ban on pharmaceutical company sponsorship of medical conferences and continuing education programs